Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
Substance Name: ONO 4641
Effect of Estrogen on Th1, Th2 and Th17 Cytokine Production by Proteolipid Protein and PHA Activated Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Patients.
Combinatorial roles for histamine H(1) -H(2) and H(3) -H(4) receptors in autoimmune inflammatory disease of the central nervous system.
Anti-JC virus antibody titres increase over time with natalizumab treatment.
Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo.
Immunosuppressive monoclonal antibodies: current and next generation.
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With Fingolimod.
Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
Memory impairment in multiple sclerosis is due to a core deficit in initial learning.
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial.
Association of STAT4 rs7574865 polymorphism with autoimmune diseases: a meta-analysis.
Towards a Classification Approach using Meta-Biclustering: Impact of Discretization in the Analysis of Expression Time Series.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy.
Dendritic cells and multiple sclerosis: disease, tolerance and therapy.
Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
In Vitro and In Vivo Models of Multiple Sclerosis.
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.
Pages
« first
‹ previous
…
206
207
208
209
210
211
212
213
214
…
next ›
last »